Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of AzaSite vs Vigamox in Tears
NCT00575367Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Mar 2008
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of AzaSite in bacterial conjunctivitis (BC), sponsored by Merck & Co.. Started Mar 2008; status: completed.
02
Drugs
AzaSite
03
Conditions
bacterial conjunctivitis (BC)
Beyond the preview
Go deeper on NCT00575367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00575367.